Defense Health Agency Contracting Activity - DHACA
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
DoW Breast Cancer, Breakthrough Award Levels 1 and 2 is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing November 18, 2026.
Overview
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification…